62 related articles for article (PubMed ID: 3708619)
1. Phase II evaluation of procarbazine in metastatic breast cancer: a Southeastern Cancer Study Group Trial.
Carpenter JT; Raney M; Logan T
Cancer Treat Rep; 1986 May; 70(5):679-80. PubMed ID: 3708619
[No Abstract] [Full Text] [Related]
2. Phase II evaluation of fludarabine in patients with metastatic breast cancer: a Southeastern Cancer Study Group trial.
Carpenter JT; Vogel CL; Wang G; Raney M
Cancer Treat Rep; 1986 Oct; 70(10):1235-6. PubMed ID: 2428493
[No Abstract] [Full Text] [Related]
3. Idarubicin in advanced breast cancer: a phase II study.
Lionetto R; Pronzato P; Conte PF; Sertoli MR; Amoroso D; Rosso R
Cancer Treat Rep; 1986 Dec; 70(12):1439-40. PubMed ID: 3466694
[TBL] [Abstract][Full Text] [Related]
4. Phase II clinical trial of acivicin in advanced breast cancer: an Eastern Cooperative Oncology Group Study.
Willson JK; Knuiman MW; Skeel RT; Wolter JM; Pandya KJ; Falkson G; Chang YC
Cancer Treat Rep; 1986 Oct; 70(10):1237-8. PubMed ID: 3530452
[No Abstract] [Full Text] [Related]
5. Phase II evaluation of aclarubicin in advanced breast cancer: a Southeastern Cancer Study Group trial.
Gockerman JP; Raney M; Logan T
Cancer Treat Rep; 1985 Sep; 69(9):1029-30. PubMed ID: 3861247
[No Abstract] [Full Text] [Related]
6. Phase II trial of aclarubicin in advanced breast cancer: a cancer and leukemia group B study.
Forastiere AA; Budman DR; Richards F; Aisner J; Weinberg V; Wood WC
Cancer Treat Rep; 1983 Dec; 67(12):1137-8. PubMed ID: 6580949
[No Abstract] [Full Text] [Related]
7. Phase II study of AMSA in patients with metastatic breast cancer: a Cancer and Leukemia Group B study.
Amrein PC; Coleman M; Richards F; Poulin RF; Bernhardt B; Ginsberg SJ; Green MR; Morrison A; Cortes E; Kiang D; Weinberg V; Wood WC
Cancer Treat Rep; 1982 May; 66(5):1211-3. PubMed ID: 6896294
[No Abstract] [Full Text] [Related]
8. Phase II trial of acivicin in advanced metastatic breast cancer.
Fleishman G; Yap HY; Murphy WK; Bodey G
Cancer Treat Rep; 1983 Sep; 67(9):843-4. PubMed ID: 6883364
[No Abstract] [Full Text] [Related]
9. Phase II trial of 6-thioguanine in metastatic breast cancer.
Pandya KJ; Tormey DC; Davis TE; Falkson G; Banerjee TK; Crowley J
Cancer Treat Rep; 1980 Jan; 64(1):191-2. PubMed ID: 7379055
[No Abstract] [Full Text] [Related]
10. Phase II study of mitoxantrone in patients with metastatic breast carcinoma: a Southeastern Cancer Study Group project.
Smalley R; Gams R
Cancer Treat Rep; 1983 Nov; 67(11):1039-40. PubMed ID: 6640553
[No Abstract] [Full Text] [Related]
11. Paclitaxel combined with weekly high-dose 5-fluorouracil/folinic acid and cisplatin in the treatment of advanced breast cancer.
Klaassen U; Wilke H; Seeber S
Semin Oncol; 1996 Oct; 23(5 Suppl 11):32-7. PubMed ID: 8893897
[TBL] [Abstract][Full Text] [Related]
12. Phase I/II study with paclitaxel in combination with weekly high-dose 5-fluorouracil/folinic acid in the treatment of metastatic breast cancer: an interim analysis.
Klaassen U; Wilke H; Pari CP; Strumberg D; Harstrick A; Eberhardt W; Becher R; Diergarten K; Seeber S
Semin Oncol; 1995 Dec; 22(6 Suppl 14):7-11. PubMed ID: 8553083
[TBL] [Abstract][Full Text] [Related]
13. Second-line chemotherapy with tauromustine in metastatic breast cancer in postmenopausal women: a phase II study.
Ernst P; Balslev I; Mouridsen HT
Cancer Treat Rep; 1987 Oct; 71(10):987-8. PubMed ID: 3652062
[No Abstract] [Full Text] [Related]
14. Weekly administration of bendamustine as salvage therapy in metastatic breast cancer: final results of a phase II study.
Eichbaum MH; Schuetz F; Khbeis T; Lauschner I; Foerster F; Sohn C; Schneeweiss A
Anticancer Drugs; 2007 Sep; 18(8):963-8. PubMed ID: 17667603
[TBL] [Abstract][Full Text] [Related]
15. Phase II study of weekly low-dose 4'-epi-doxorubicin in advanced postmenopausal breast cancer.
Jones WG; Mattsson W
Cancer Treat Rep; 1984 Apr; 68(4):675-7. PubMed ID: 6585271
[TBL] [Abstract][Full Text] [Related]
16. [Phase II study of THP (2''R)-4'-0-tetrahydropyranyladriamycin) in breast cancer].
Abe O; Enomoto K; Tominaga T; Kasai Y; Soejima S; Kasai M; Izuo M; Yoshida M; Kubo K; Terasawa T
Gan To Kagaku Ryoho; 1986 Mar; 13(3 Pt 1):578-85. PubMed ID: 3954379
[TBL] [Abstract][Full Text] [Related]
17. Phase II study of lonidamine in patients with metastatic breast cancer: a National Cancer Institute of Canada Clinical Trials Group Study.
Band PR; Maroun J; Pritchard K; Stewart D; Coppin CM; Wilson K; Eisenhauer EA
Cancer Treat Rep; 1986 Nov; 70(11):1305-10. PubMed ID: 3768873
[TBL] [Abstract][Full Text] [Related]
18. Phase II trial of acivicin in advanced breast carcinoma: a Cancer and Leukemia Group B Study.
Booth BW; Korzun AH; Weiss RB; Ellison RR; Budman D; Khojasteh A; Wood W
Cancer Treat Rep; 1986 Oct; 70(10):1247-8. PubMed ID: 3530455
[No Abstract] [Full Text] [Related]
19. [A phase II study of 590-S (1-phthalidyl-5-fluorouracil) in patients with breast cancer--multi-center cooperative study--Cooperative Study Group of 590-S in Breast Cancer].
Taguchi T; Terasawa T
Gan To Kagaku Ryoho; 1987 Feb; 14(2):467-71. PubMed ID: 3813575
[TBL] [Abstract][Full Text] [Related]
20. Phase II study of vindesine in patients with metastatic breast cancer.
Cobleigh MA; Williams SD; Einhorn LH
Cancer Treat Rep; 1981; 65(7-8):659-63. PubMed ID: 7248983
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
